Wp. Zou et al., Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells, NAT MED, 7(12), 2001, pp. 1339-1346
Citations number
47
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research General Topics
Dendritic-cell (DQ trafficking and function in tumors is poorly characteriz
ed, with studies confined to myeloid DCs (DC1s). Tumors inhibit DC1 migrati
on and function, likely hindering specific immunity. The role of plasmacyto
id DCs (DC2s) in tumor immunity is unknown. We show here that malignant hum
an ovarian epithelial tumor cells express very: high levels of stromal-deri
ved factor-1, which induces DC2 precursor (preDC2) chemotaxis and adhesion/
transmigration, upregulates preDC2 very late antigen (VLA)-5, and protects
preDC2s from tumor macrophage interleukin-10-induced apoptosis, all through
CXC chemokine receptor-4. The VLA-5 ligand vascular-cell adhesion molecule
-1 mediated preDC2 adhesion/transmig ration. Tumor preDC2s induced signific
ant T-cell interleukin-10 unrelated to preDC2 differentiation or activation
state, and this contributed to poor T-cell activation. Myeloid precursor D
Cs (preDC1s) were not detected. Tumors may weaken immunity by attracting pr
eDC2s and protecting them from the harsh microenvironment, and by altering
preDC1 distribution.